Global support for a quality solution
We lead innovation in peptide API’s to the benefit of millions of patients
Contact us"We are proud to support our customers to the benefit of millions of patients"
<2 minutes with Raymond De Vré, CEO
watch the videoAhead on green peptide chemistry
Together we improve process performance while reducing the environmental footprint
Learn moreMarket leader in peptide API manufacturing and services
PolyPeptide is a Contract Development & Manufacturing Organization (CDMO) supporting pharmaceutical and biotech companies in the development and manufacturing of proprietary and generic active pharmaceutical ingredients (API).
PolyPeptide with encouraging progress within custom projects pipeline – however with lower profitability in the first half of 2022
19 Aug 2022 - Baar, 19 August 2022 – PolyPeptide Group AG (SIX: PPGN), a focused global CDMO for peptide- and oligo-nucleotide-based active pharmaceutical ingredients, today announced its detailed results […]
Read morePolyPeptide provides market update
12 Jul 2022 - Media Release – ad hoc announcement pursuant to Art. 53 LR Baar, 12 July 2022 – PolyPeptide Group AG (PolyPeptide), a global leader in peptide and […]
Read more